Calliditas Therapeutics AB (CALT) Stock Analyst Ratings
NASDAQ:CALT - Nasdaq - US13124Q1067 - ADR - Currency: USD
ChartMill assigns a Buy % Consensus number of 82% to CALT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 45.37. This target is 13.42% above the current price.
CALT was analyzed by 13 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about CALT.
In the previous month the buy percentage consensus was at a similar level.
CALT was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-31 | Citigroup | Downgrade | Buy -> Neutral |
| 2024-05-28 | Stifel | Downgrade | Buy -> Hold |
| 2024-05-28 | Jefferies | Downgrade | Buy -> Hold |
| 2024-05-28 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-05-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-18 | Guggenheim | Maintains | Neutral -> Neutral |
| 2023-06-20 | HC Wainwright & Co. | Initiate | Buy |
| 2023-03-01 | Guggenheim | Initiate | Neutral |
| 2023-02-24 | Citigroup | Maintains | Buy |
| 2021-12-20 | HC Wainwright & Co. | Maintains | Buy |